You are here

Disease

Use of Covid antiviral medicineby infected Americans remains low --study

 

A new report published in Open Forum Infectious Diseases demonstrates that, despite the proven effectiveness of Paxlovid and molnupiravir against severe COVID-19 outcomes, uptake of these two antivirals remains low among Americans with COVID.

...

 

Country / Region Tags: 
Problem, Solution, SitRep, or ?: 

Respiratory virus levels climb as JN.1 variant dominates COVID cases

 

... In its tracking of three main viruses that drive visits to health providers for symptoms such as fever and sore throat, the CDC said respiratory syncytial virus (RSV) activity remains elevated, especially for young children. Meanwhile, COVID-19 activity is increasing in many parts of the country, as is seasonal flu, though hospital bed occupancy and intensive care unit (ICU) capacity for all patients remains stable.

...

..

 

Country / Region Tags: 
Problem, Solution, SitRep, or ?: 

New JN.1 COVID variant may be more contagious but less severe

 

A new, fast-spreading variant named JN.1 now makes up 44% of all cases nationwide, more than doubling (21.3% vs. 44.2%) its share from the week before, according to the CDC COVID Data Tracker: Variant Proportions. ...

Country / Region Tags: 
Problem, Solution, SitRep, or ?: 

No consistent link found between antiviral drugs like Paxlovid and COVID rebound --U.S.G. reviews

 

Two systematic reviews by US federal agencies on the possible link between antiviral treatment for COVID-19 and viral rebound—one specifically on Paxlovid—find no consistent association. The studies were published yesteray in Morbidity and Mortality Weekly Report.

...

 

 

Country / Region Tags: 
Problem, Solution, SitRep, or ?: 

Pages

Subscribe to Disease
howdy folks